Panel Discussion: What Does a ‘Good Enough’ Potency Assay Panel Look Like?

9:00 am - Wednesday 6th May 2026

  • Exploring why some teams still run ddPCR, ELISA, AUC, HPLC and TEM and how to reduce redundancy
  • Discussing opportunities for how early teams can converge on a smaller assay panel
  • Is there a one-size-fits-all, and how close are we to establishing one?

Speakers:

Debojit Bose
Principal Scientist
Regeneron Pharmaceuticals
Ian Anderson
Director - Analytical Sciences Technology & Manufacturing Science & Technology
Orchard Therapeutics